170 related articles for article (PubMed ID: 27381084)
1. Synthesis of MR-49, a deiodinated analog of tetraiodothyroacetic acid (tetrac), as a novel pro-angiogenesis modulator.
Rajabi M; Sudha T; Darwish NH; Davis PJ; Mousa SA
Bioorg Med Chem Lett; 2016 Aug; 26(16):4112-6. PubMed ID: 27381084
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer.
Rajabi M; Yalcin M; Mousa SA
Bioorg Med Chem Lett; 2018 Apr; 28(7):1223-1227. PubMed ID: 29519736
[TBL] [Abstract][Full Text] [Related]
3. The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin.
Mousa SA; O'Connor LJ; Bergh JJ; Davis FB; Scanlan TS; Davis PJ
J Cardiovasc Pharmacol; 2005 Sep; 46(3):356-60. PubMed ID: 16116342
[TBL] [Abstract][Full Text] [Related]
4. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
Davis PJ; Lin HY; Hercbergs A; Mousa SA
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
[TBL] [Abstract][Full Text] [Related]
5. Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.
Yalcin M; Bharali DJ; Dyskin E; Dier E; Lansing L; Mousa SS; Davis FB; Davis PJ; Mousa SA
Thyroid; 2010 Mar; 20(3):281-6. PubMed ID: 20187783
[TBL] [Abstract][Full Text] [Related]
6. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
[TBL] [Abstract][Full Text] [Related]
7. Tetrac as an anti-angiogenic agent in cancer.
Schmohl KA; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2019 Jun; 26(6):R287-R304. PubMed ID: 31063970
[TBL] [Abstract][Full Text] [Related]
8. Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac.
Davis PJ; Glinsky GV; Lin HY; Leith JT; Hercbergs A; Tang HY; Ashur-Fabian O; Incerpi S; Mousa SA
Front Endocrinol (Lausanne); 2014; 5():240. PubMed ID: 25628605
[TBL] [Abstract][Full Text] [Related]
9. Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model.
Mousa SA; Davis FB; Mohamed S; Davis PJ; Feng X
Int Angiol; 2006 Dec; 25(4):407-13. PubMed ID: 17164749
[TBL] [Abstract][Full Text] [Related]
10. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface.
Davis FB; Mousa SA; O'Connor L; Mohamed S; Lin HY; Cao HJ; Davis PJ
Circ Res; 2004 Jun; 94(11):1500-6. PubMed ID: 15117822
[TBL] [Abstract][Full Text] [Related]
11. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
12. Bioactivity of Thyroid Hormone Analogs at Cancer Cells.
Davis PJ; Tang HY; Hercbergs A; Lin HY; Keating KA; Mousa SA
Front Endocrinol (Lausanne); 2018; 9():739. PubMed ID: 30564196
[TBL] [Abstract][Full Text] [Related]
13. Nongenomic Actions of Thyroid Hormone: The Integrin Component.
Davis PJ; Mousa SA; Lin HY
Physiol Rev; 2021 Jan; 101(1):319-352. PubMed ID: 32584192
[TBL] [Abstract][Full Text] [Related]
14. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
Davis PJ; Davis FB; Mousa SA; Luidens MK; Lin HY
Annu Rev Pharmacol Toxicol; 2011; 51():99-115. PubMed ID: 20868274
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone deiodination pathways in brain and liver of rainbow trout, Oncorhynchus mykiss.
Frith SD; Eales JG
Gen Comp Endocrinol; 1996 Mar; 101(3):323-32. PubMed ID: 8729942
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone and angiogenesis.
Luidens MK; Mousa SA; Davis FB; Lin HY; Davis PJ
Vascul Pharmacol; 2010; 52(3-4):142-5. PubMed ID: 19879961
[TBL] [Abstract][Full Text] [Related]
17. Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3'-triiodo-L-thyronine or diiodothyropropionic acid (DITPA).
Mousa SS; Davis FB; Davis PJ; Mousa SA
Clin Appl Thromb Hemost; 2010 Jun; 16(3):288-93. PubMed ID: 19903697
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone analogues potentiate the antiviral action of interferon-gamma by two mechanisms.
Lin HY; Thacore HR; Davis FB; Davis PJ
J Cell Physiol; 1996 May; 167(2):269-76. PubMed ID: 8613467
[TBL] [Abstract][Full Text] [Related]
19. Actions of Thyroid Hormone Analogues on Chemokines.
Davis PJ; Glinsky GV; Lin HY; Mousa SA
J Immunol Res; 2016; 2016():3147671. PubMed ID: 27493972
[TBL] [Abstract][Full Text] [Related]
20. Thyroid Hormone, Hormone Analogs, and Angiogenesis.
Davis PJ; Sudha T; Lin HY; Mousa SA
Compr Physiol; 2015 Dec; 6(1):353-62. PubMed ID: 26756636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
